Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: July 2012

Chapter 16 - Autism spectrum disorders


This chapter describes the syndromes of mild cognitive impairment (MCI) and Alzheimer's disease (AD). Many elderly persons exhibit MCI, characterized by memory complaints and mild abnormalities of performance on formal tests, associated with intact general cognition and preserved activities of daily living. The clinical manifestations of AD arise from abnormalities involving brain regions and neural circuits composed of populations of neurons that are essential for memory, learning, and cognitive performance. Early information about the involvement of neurotransmitter-specific circuits damaged by the disease led to the design of early therapies for AD. The genetics of AD are complex, often influencing phenotype in an age-dependent manner. Late onset cases of AD without clear familial association reflect the influences of a variety of risk factors. The chapter emphasizes the need for safe and effective mechanism-based therapies for AD. New treatments will probably require combinatorial approaches.


AbrahamsBS, GeschwindDH. 2008. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9:341–355.
AlarconM, YonanAL, GilliamTC, CantorRM, GeschwindDH. 2005. Quantitative genome scan and Ordered-Subsets Analysis of autism endophenotypes support language QTLs. Mol Psychiatry 10:747–757.
Alonso-BuaB, DiazF, FerracesMJ. 2006. The contribution of AERPs (MMN and LDN) to studying temporal vs. linguistic processing deficits in children with reading difficulties. Int J Psychophysiol 59:159–167.
AmirRE, Van den VeyverIB, WanMet al. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188.
AnneyR, KleiL, PintoDet al. 2010. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 19:4072–4082.
ArndtTL, StodgellCJ, RodierPM. 2005. The teratology of autism. Int J Dev Neurosci 23:189–199.
BellBB, AbelLA, LiW, ChristianJC, YeeRD. 1994. Concordance of smooth pursuit and saccadic measures in normal monozygotic twin pairs. Biol Psychiatry 36:522–526.
BenasichAA, GouZ, ChoudhuryN, HarrisKD. 2008. Early cognitive and language skills are linked to resting frontal gamma power across the first 3 years. Behav Brain Res 195:215–222.
BenasichAA, TallalP. 2002. Infant discrimination of rapid auditory cues predicts later language impairment. Behav Brain Res 136:31–49.
BerensP, KelirisGA, EckerAS, LogothetisNK, ToliasAS. 2008. Comparing the feature selectivity of the gamma-band of the local field potential and the underlying spiking activity in primate visual cortex. Front Syst Neurosci 2:2.
Berry-KravisE, HesslD, CoffeySet al. 2009. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 46:266–271.
BetancurC. 2011. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42–77.
BetancurC, SakuraiT, BuxbaumJD. 2009. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci 32:402–412.
BiglerED, MortensenS, NeeleyESet al. 2007. Superior temporal gyrus, language function, and autism. Dev Neuropsychol 31:217–238.
BlueME. 2009. Serotonin dysfunction in autism. In: Autism: Current Theories and Evidence. ZimmermanAW, ed. Totowa, NJ: Humana Press, pp. 111–132.
BlundellJ, BlaissCA, EthertonMRet al. 2010. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci 30:2115–2129.
BlundellJ, TabuchiK, BolligerMFet al. 2009. Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav 8:114–126.
BourgeronT. 2009. A synaptic trek to autism. Curr Opin Neurobiol 19:231–234.
BozdagiO, SakuraiT, PapapetrouDet al. 2010. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 1:15.
BraeutigamS, BaileyAJ, SwithenbySJ. 2001. Phase-locked gamma band responses to semantic violation stimuli. Brain Res Cogn Brain Res 10:365–377.
BraeutigamS, SwithenbySJ, BaileyAJ. 2008. Contextual integration the unusual way: a magnetoencephalographic study of responses to semantic violation in individuals with autism spectrum disorders. Eur J Neurosci 27:1026–1036.
BraffDL, FreedmanR, SchorkNJ, Gottesman, II. 2007. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:21–32.
BrodkinES. 2007. BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behav Brain Res 176:53–65.
BrodkinES, HagemannA, NemetskiSM, SilverLM. 2004. Social approach–avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain Res 1002:151–157.
BromleyRL, BakerGA, MeadorKJ. 2009. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr OpinNeurol 22:162–166.
BromleyRL, MawerG, Clayton-SmithJ, BakerGA. 2008. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 71:1923–1924.
BruneauN, RouxS, AdrienJL, BarthelemyC. 1999. Auditory associative cortex dysfunction in children with autism: evidence from late auditory evoked potentials (N1 wave-T complex). Clin Neurophysiol 110:1927–1934.
BuhlDL, HarrisKD, HormuzdiSG, MonyerH, BuzsakiG. 2003. Selective impairment of hippocampal gamma oscillations in connexin-36 knock-out mouse in vivo. J Neurosci 23:1013–1018.
CantorRM, KonoN, DuvallJAet al. 2005. Replication of autism linkage: fine-mapping peak at 17q21. Am J Hum Genet 76:1050–1056.
ChadmanKK, GongS, ScattoniMLet al. 2008. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res 1:147–158.
ChadmanKK, YangM, CrawleyJN. 2009. Criteria for validating mouse models of psychiatric diseases. Am J Med Genet B Neuropsychiatr Genet 150B:1–11.
ChandanaSR, BehenME, JuhaszCet al. 2005. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci 23:171–182.
ChangQ, KhareG, DaniV, NelsonS, JaenischR. 2006. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49:341–348.
ChaoHT, ChenH, SamacoRCet al. 2010. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468:263–269.
CharmanT, Baron-CohenS, SwettenhamJet al. 2003. Predicting language outcome in infants with autism and pervasive developmental disorder. Int J Lang Commun Disord 38:265–285.
ChehMA, MillonigJH, RoselliLMet al. 2006. En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res 1116:166–176.
ChenRZ, AkbarianS, TudorM, JaenischR. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327–331.
ChessS, FernandezP, KornS. 1978. Behavioral consequences of congenital rubella. J Pediatr 93:699–703.
CobenR, ClarkeAR, HudspethW, BarryRJ. 2008. EEG power and coherence in autistic spectrum disorder. Clin Neurophysiol 119:1002–1009.
ConciatoriM, StodgellCJ, HymanSLet al. 2004. Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry 55:413–419.
ConstantinoJN, LajonchereC, LutzMet al. 2006. Autistic social impairment in the siblings of children with pervasive developmental disorders. Am J Psychiatry 163:294–296.
CrawleyJN. 2004. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 10:248–258.
CrawleyJ. 2007a. What's Wrong With My Mouse: Behavioral Phenotyping of Transgenic and Knockout Mice, 2nd edn. Hoboken,NJ: Wiley-Liss.
CrawleyJN. 2007b. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 17:448–459.
CrawleyJN. 2008. Behavioral phenotyping strategies for mutant mice. Neuron 57:809–818.
CurrentiSA. 2010. Understanding and determining the etiology of autism. Cell Mol Neurobiol 30:161–171.
CurtisJT, HoodAN, ChenY, CobbGP, WallaceDR. 2010. Chronic metals ingestion by prairie voles produces sex-specific deficits in social behavior: an animal model of autism. Behav Brain Res 213:42–49.
de VrijFM, LevengaJ, van der LindeHCet al. 2008. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31:127–132.
DeLoreyTM, SahbaieP, HashemiE, HomanicsGE, ClarkJD. 2008. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res 187:207–220.
DeLoreyTM, SahbaieP, HashemiE, LiWW, SalehiA, ClarkDJ. 2011. Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. Behav Brain Res 216:36–45.
DevlinB, CookEH, Jr., CoonHet al. 2005. Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 10:1110–1116.
DiedlerJ, PietzJ, BrunnerMet al. 2009. Auditory processing in children with language-based learning problems: a magnetoencephalography study. Neuroreport 20:844–848.
DockendorffTC, SuHS, McBrideSMet al. 2002. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34:973–984.
DurandCM, BetancurC, BoeckersTMet al. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39:25–27.
DyerC. 2010. Thiomersal does not cause autism, US court finds. Br Med J 340:c1518.
EhningerD, HanS, ShilyanskyCet al. 2008. Reversal of learning deficits in a Tsc2+/-mouse model of tuberous sclerosis. Nat Med 14:843–848.
EhningerD, SilvaAJ. 2011. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol Med 17:78–87.
EhretG. 1987. Left hemisphere advantage in the mouse brain for recognizing ultrasonic communication calls. Nature 325:249–251.
EhrlichmanRS, LuminaisSN, WhiteSLet al. 2009. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res 1294:116–127.
EhrlichmanRS, MaxwellCR, MajumdarS, SiegelSJ. 2008. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice. J Cogn Neurosci 20:1403–1414.
EnardW, GehreS, HammerschmidtKet al. 2009. A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 137:961–971.
EnstromAM, Van de WaterJA, AshwoodP. 2009. Autoimmunity in autism. Curr Opin Investig Drugs 10:463–473.
Escalante-MeadPR, MinshewNJ, SweeneyJA. 2003. Abnormal brain lateralization in high-functioning autism. J Autism Dev Disord 33:539–543.
EthertonMR, BlaissCA, PowellCM, SudhofTC. 2009. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci USA 106:17998–18003.
European Chromosome 16 Tuberous Sclerosis Consortium 1993. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315.
FatemiSH, EarleJ, KanodiaRet al. 2002. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22:25–33.
FergusonJN, YoungLJ, HearnEFet al. 2000. Social amnesia in mice lacking the oxytocin gene. Nat Genet 25:284–288.
FidlerDJ, BaileyJN, SmalleySL. 2000. Macrocephaly in autism and other pervasive developmental disorders. Dev Med Child Neurol 42:737–740.
FlaggEJ, CardyJE, RobertsW, RobertsTP. 2005. Language lateralization development in children with autism: insights from the late field magnetoencephalogram. Neurosci Lett 386:82–87.
FranklandPW, WangY, RosnerBet al. 2004. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417–425.
GageNM, SiegelB, CallenM, RobertsTP. 2003. Cortical sound processing in children with autism disorder: an MEG investigation. Neuroreport 14:2047–2051.
GandalMJ, EdgarJC, EhrlichmanRSet al. 2010. Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism. Biol Psychiatry 68:1100–1106.
GeyerMA, McIlwainKL, PaylorR. 2002. Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 7:1039–1053.
GibsonJR, BartleyAF, HaysSA, HuberKM. 2008. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol 100:2615–2626.
GlessnerJT, WangK, CaiGet al. 2009. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569–573.
GogollaN, LeblancJJ, QuastKBet al. 2009. Common circuit defect of excitatory–inhibitory balance in mouse models of autism. J Neurodev Disord 1:172–181.
GoinesP, Van de WaterJ. 2010. The immune system's role in the biology of autism. Curr Opin Neurol 23:111–117.
GoldbergJ, AndersonGM, ZwaigenbaumLet al. 2009. Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. J Autism Dev Disord 39:97–104.
GoordenSM, van WoerdenGM, van der WeerdL, CheadleJP, ElgersmaY. 2007. Cognitive deficits in Tsc1+/− mice in the absence of cerebral lesions and seizures. Ann Neurol 62:648–655.
Gottesman, II, ShieldsJ. 1973. Genetic theorizing and schizophrenia. Br J Psychiatry 122:15–30.
Gottesman, II, GouldTD. 2003. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645.
GourbalBE, BarthelemyM, PetitG, GabrionC. 2004. Spectrographic analysis of the ultrasonic vocalisations of adult male and female BALB/c mice. Naturwissenschaften 91:381–385.
GutierrezRC, HungJ, ZhangYet al. 2009. Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3. Neuroscience 162:208–221.
GuyJ, GanJ, SelfridgeJ, CobbS, BirdA. 2007. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143–1147.
GuyJ, HendrichB, HolmesM, MartinJE, BirdA. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322–326.
HallSD, HollidayIE, HillebrandAet al. 2005. The missing link: analogous human and primate cortical gamma oscillations. Neuroimage 26:13–17.
HamalainenMS. 1992. Magnetoencephalography: a tool for functional brain imaging. Brain Topogr 5:95–102.
HenzeDA, BorhegyiZ, CsicsvariJet al. 2000. Intracellular features predicted by extracellular recordings in the hippocampus in vivo. J Neurophysiol 84:390–400.
HerbertMR. 2010. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol 23:103–110.
HerrmannCS, FrundI, LenzD. 2010. Human gamma-band activity: a review on cognitive and behavioral correlates and network models. Neurosci Biobehav Rev 34:981–992.
HeyserCJ. 2004. Assessment of developmental milestones in rodents. Curr Protoc Neurosci Ch. 8: Unit 8.18.
HigginsGA, BreysseN. 2008. Rodent model of attention: the 5-choice serial reaction time task. Curr Protoc Pharmacol 41:5.49.41–45.49.20.
HillebrandA, SinghKD, HollidayIE, FurlongPL, BarnesGR. 2005. A new approach to neuroimaging with magnetoencephalography. Hum Brain Mapp 25:199–211.
HiroiN, ZhuH, LeeMet al. 2005. A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. Proc Natl Acad Sci USA 102:19132–19137.
HoefferCA, KlannE. 2010. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33:67–75.
HoferMA, ShairHN, BrunelliSA. 2002. Ultrasonic vocalizations in rat and mouse pups. Curr Protoc Neurosci Ch. 8: Unit 8.14.
HollanderE, KolevzonA, CoyleJT, eds. 2011. Textbook of Autism Spectrum Disorders. Washington, DC: American Psychiatric Publishing.
HolyTE, GuoZ. 2005. Ultrasonic songs of male mice. PLoS Biol 3: e386.
HonagaE, IshiiR, KurimotoRet al. 2010. Post-movement beta rebound abnormality as indicator of mirror neuron system dysfunction in autistic spectrum disorder: an MEG study. Neurosci Lett 478:141–145.
HornigM, ChianD, LipkinWI. 2004. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9:833–845.
HuberKM, GallagherSM, WarrenST, BearMF. 2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746–7750.
IngramJL, PeckhamSM, TisdaleB, RodierPM. 2000. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22:319–324.
InselTR. 1997. A neurobiological basis of social attachment. Am J Psychiatry 154:726–735.
IslerJR, MartienKM, GrievePG, StarkRI, HerbertMR. 2010. Reduced functional connectivity in visual evoked potentials in children with autism spectrum disorder. Clin Neurophysiol 121:2035–2043.
JahromiLB, KasariCL, McCrackenJTet al. 2009. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord 39:395–404.
JamainS, RadyushkinK, HammerschmidtKet al. 2008. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci USA 105:1710–1715.
JamainS, QuachH, BetancurCet al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27–29.
JangSW, LiuX, YepesMet al. 2010. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci USA 107:2687–2692.
JensenO, GoelP, KopellNet al. 2005. On the human sensorimotor-cortex beta rhythm: sources and modeling. Neuroimage 26:347–355.
JesnerOS, Aref-AdibM, CorenE. 2007. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev: CD005040.
JesteSS, NelsonCA, 3rd. 2009. Event related potentials in the understanding of autism spectrum disorders: an analytical review. J Autism Dev Disord 39:495–510.
KasaiK, HashimotoO, KawakuboYet al. 2005. Delayed automatic detection of change in speech sounds in adults with autism: a magnetoencephalographic study. Clin Neurophysiol 116:1655–1664.
KatznerS, NauhausI, BenucciAet al. 2009. Local origin of field potentials in visual cortex. Neuron 61:35–41.
KimJY, DuanX, LiuCYet al. 2009. DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. Neuron 63:761–773.
KinneyDK, BarchDH, ChaykaB, NapoleonS, MunirKM. 2010. Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder?Med Hypotheses 74:102–106.
KleinhansNM, MullerRA, CohenDN, CourchesneE. 2008. Atypical functional lateralization of language in autism spectrum disorders. Brain Res 1221:115–125.
KolozsiE, MackenzieRN, RoulletFI, de CatanzaroD, FosterJA. 2009. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience 163:1201–1210.
KooyRF. 2003. Of mice and the fragile X syndrome. Trends Genet 19:148–154.
KosfeldM, HeinrichsM, ZakPJ, FischbacherU, FehrE. 2005. Oxytocin increases trust in humans. Nature 435:673–676.
KreyJF, DolmetschRE. 2007. Molecular mechanisms of autism: a possible role for Ca2+ signaling. Curr Opin Neurobiol 17:112–119.
KruegerDD, BearMF. 2011. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62:411–429.
KujalaT, LepistoT, Nieminen-von WendtT, NaatanenP, NaatanenR. 2005. Neurophysiological evidence for cortical discrimination impairment of prosody in Asperger syndrome. Neurosci Lett 383:260–265.
KwonCH, LuikartBW, PowellCMet al. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377–388.
LahvisGP, AllevaE, ScattoniML. 2011. Translating mouse vocalizations: prosody and frequency modulation (1). Genes Brain Behav 10:4–16.
LamKS, AmanMG, ArnoldLE. 2006. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27:254–289.
LandriganPJ. 2010. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 22:219–225.
LangeN, DubrayMB, LeeJEet al. 2010. Atypical diffusion tensor hemispheric asymmetry in autism. Autism Res 3:350–358.
LeeLC, ZacharyAA, LeffellMSet al. 2006. HLA-DR4 in families with autism. Pediatr Neurol 35:303–307.
LevinED, AddyN, NakajimaAet al. 2001. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res 130:83–89.
LevinR, Heresco-LevyU, Bachner-MelmanRet al. 2009. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology 34:901–908.
LevittP, CampbellDB. 2009. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest 119:747–754.
LevySE, HymanSL. 2008. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 17:803–820, ix.
LevySE, MandellDS, SchultzRT. 2009. Autism. Lancet 374:1627–1638.
LewisMH, TanimuraY, LeeLW, BodfishJW. 2007. Animal models of restricted repetitive behavior in autism. Behav Brain Res 176:66–74.
LibbeyJE, SweetenTL, McMahonWM, FujinamiRS. 2005. Autistic disorder and viral infections. J Neurovirol 11:1–10.
LijamN, PaylorR, McDonaldMPet al. 1997. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90:895–905.
LindzeyG, WinstonH, ManosevitzM. 1961. Social dominance in inbred mouse strains. Nature 191:474–476.
LiuRC, MillerKD, MerzenichMM, SchreinerCE. 2003. Acoustic variability and distinguishability among mouse ultrasound vocalizations. J Acoust Soc Am 114:3412–3422.
LonettiG, AngelucciA, MorandoLet al. 2010. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry 67:657–665.
LordC, RisiS, LambrechtLet al. 2000. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205–223.
LordC, RutterM, Le CouteurA. 1994. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659–685.
LugenbeelKA, PeierAM, CarsonNL, ChudleyAE, NelsonDL. 1995. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nat Genet 10:483–485.
MarkramH, RinaldiT, MarkramK. 2007. The intense world syndrome – an alternative hypothesis for autism. Front Neurosci 1:77–96.
MarkramK, RinaldiT, La MendolaD, SandiC, MarkramH. 2008. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33:901–912.
MassaSM, YangT, XieYet al. 2010. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 120:1774–1785.
MaziadeM, MeretteC, CayerMet al. 2000. Prolongation of brainstem auditory-evoked responses in autistic probands and their unaffected relatives. Arch Gen Psychiatry 57:1077–1083.
McAlonanGM, DalyE, KumariVet al. 2002. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 125:1594–1606.
McBrideSM, ChoiCH, WangYet al. 2005. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45:753–764.
McFarlaneHG, KusekGK, YangMet al. 2008. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 7:152–163.
MeadorKJ, BakerGA, BrowningNet al. 2009. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597–1605.
MeikleL, PollizziK, EgnorAet al. 2008. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28:5422–5432.
MescherM, MerkleH, KirschJ, GarwoodM, GruetterR. 1998. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11:266–272.
MesseriP, EleftheriouBE, OliverioA. 1975. Dominance behavior: a phylogenetic analysis in the mouse. Physiol Behav 14:53–58.
MeyerP, MecklingerA, GrunwaldTet al. 2005. Language processing within the human medial temporal lobe. Hippocampus 15:451–459.
MillerMT, StromlandK, VenturaLet al. 2005. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int J Dev Neurosci 23:201–219.
MilneE, ScopeA, PascalisO, BuckleyD, MakeigS. 2009. Independent component analysis reveals atypical electroencephalographic activity during visual perception in individuals with autism. Biol Psychiatry 65:22–30.
MolesA, CostantiniF, GarbuginoL, ZanettiniC, D'AmatoFR. 2007. Ultrasonic vocalizations emitted during dyadic interactions in female mice: a possible index of sociability?Behav Brain Res 182:223–230.
MoonJ, BeaudinAE, VeroskySet al. 2006. Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome. Behav Neurosci 120:1367–1379.
MoralesJ, HiesingerPR, SchroederAJet al. 2002. Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34:961–972.
MorrowEM, YooSY, FlavellSWet al. 2008. Identifying autism loci and genes by tracing recent shared ancestry. Science 321:218–223.
MosconiMW, KayM, D'CruzAMet al. 2010. Neurobehavioral abnormalities in first-degree relatives of individuals with autism. Arch Gen Psychiatry 67:830–840.
MoySS, NadlerJJ. 2008. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 13:4–26.
MoySS, NadlerJJ, PoeMDet al. 2008. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 188:178–194.
MoySS, NadlerJJ, YoungNBet al. 2007. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 176:4–20.
MoySS, NonnemanRJ, YoungNB, DemyanenkoGP, ManessPF. 2009. Impaired sociability and cognitive function in Nrcam-null mice. Behav Brain Res 205:123–131.
MuriasM, WebbSJ, GreensonJ, DawsonG. 2007. Resting state cortical connectivity reflected in EEG coherence in individuals with autism. Biol Psychiatry 62:270–273.
MuscarellaLA, GuarnieriV, SaccoRet al. 2007. HOXA1 gene variants influence head growth rates in humans. Am J Med Genet B Neuropsychiatr Genet 144B:388–390.
MuthukumaraswamySD, EddenRA, JonesDK, SwettenhamJB, SinghKD. 2009. Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci USA 106:8356–8361.
NaatanenR, PaavilainenP, AlhoK, ReinikainenK, SamsM. 1987. The mismatch negativity to intensity changes in an auditory stimulus sequence. Electroencephalogr Clin Neurophysiol Suppl 40:125–131.
NadlerJJ, MoySS, DoldGet al. 2004. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3:303–314.
NakamuraK, SekineY, OuchiYet al. 2010. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 67:59–68.
Network RUoPPA. 2005. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62:1266–1274.
Nickl-JockschatT, MichelTM. 2011. The role of neurotrophic factors in autism. Mol Psychiatry 16:478–490.
NybyJ. 1983. Ultrasonic vocalizations during sex behavior of male house mice (Mus musculus): a description. Behav Neural Biol 39:128–134.
Oram CardyJE, FlaggEJ, RobertsW, BrianJ, RobertsTP. 2005a. Magnetoencephalography identifies rapid temporal processing deficit in autism and language impairment. Neuroreport 16:329–332.
Oram CardyJE, FlaggEJ, RobertsW, RobertsTP. 2005b. Delayed mismatch field for speech and non-speech sounds in children with autism. Neuroreport 16:521–525.
Oram CardyJE, FlaggEJ, RobertsW, RobertsTP. 2008. Auditory evoked fields predict language ability and impairment in children. Int J Psychophysiol 68:170–175.
OrekhovaEV, StroganovaTA, NygrenGet al. 2007. Excess of high frequency electroencephalogram oscillations in boys with autism. Biol Psychiatry 62:1022–1029.
OrlovaKA, CrinoPB. 2010. The tuberous sclerosis complex. Ann NY Acad Sci 1184:87–105.
PageDT, KutiOJ, PrestiaC, SurM. 2009. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci USA 106:1989–1994.
PalmenSJ, van EngelandH, HofPR, SchmitzC. 2004. Neuropathological findings in autism. Brain 127:2572–2583.
PankseppJB, JochmanKA, KimJUet al. 2007. Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice. PLoS One 2:e351.
PantevC, MakeigS, HokeMet al. 1991. Human auditory evoked gamma-band magnetic fields. Proc Natl Acad Sci USA 88:8996–9000.
PaylorR, GlaserB, MupoAet al. 2006. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103:7729–7734.
PerryW, MinassianA, LopezB, MaronL, LincolnA. 2007. Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61:482–486.
PersicoAM, BourgeronT. 2006. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29:349–358.
PessahIN, SeegalRF, LeinPJet al. 2008. Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology 29:532–545.
PivenJ, TsaiGC, NehmeEet al. 1991. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 21:51–59.
PriceCS, ThompsonWW, GoodsonBet al. 2010. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 126:656–664.
PruskyGT, WestPW, DouglasRM. 2000. Behavioral assessment of visual acuity in mice and rats. Vision Res 40:2201–2209.
PuzzoI, CooperNR, VetterP, RussoR. 2010. EEG activation differences in the pre-motor cortex and supplementary motor area between normal individuals with high and low traits of autism. Brain Res 1342:104–110.
RasalamAD, HaileyH, WilliamsJHet al. 2005. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47:551–555.
RauhVA, GarfinkelR, PereraFPet al. 2006. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 118:e1845–1859.
RestivoL, FerrariF, PassinoEet al. 2005. Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc Natl Acad Sci USA 102:11557–11562.
RicceriL, MolesA, CrawleyJ. 2007. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behav Brain Res 176:40–52.
RinaldiT, KulangaraK, AntonielloK, MarkramH. 2007. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA 104:13501–13506.
RobertsTP, FerrariP, StufflebeamSM, PoeppelD. 2000. Latency of the auditory evoked neuromagnetic field components: stimulus dependence and insights toward perception. J Clin Neurophysiol 17:114–129.
RobertsTP, KhanSY, BlaskeyLet al. 2009. Developmental correlation of diffusion anisotropy with auditory-evoked response. Neuroreport 20:1586–1591.
RobertsTP, KhanSY, ReyMet al. 2010. MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism. Autism Res 3:8–18.
RobertsTP, SchmidtGL, EgethMet al. 2008. Electrophysiological signatures: magnetoencephalographic studies of the neural correlates of language impairment in autism spectrum disorders. Int J Psychophysiol 68:149–160.
RodierPM, IngramJL, TisdaleB, NelsonS, RomanoJ. 1996. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 370:247–261.
RojasDC, MaharajhK, TealeP, RogersSJ. 2008. Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism. BMC Psychiatry 8:66.
RoopunAK, MiddletonSJ, CunninghamMOet al. 2006. A beta2-frequency (20–30 Hz) oscillation in nonsynaptic networks of somatosensory cortex. Proc Natl Acad Sci USA 103:15646–15650.
RubensteinJL, MerzenichMM. 2003. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255–267.
RujescuD, IngasonA, CichonSet al. 2009. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18:988–996.
SaresellaM, MarventanoI, GueriniFRet al. 2009. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry 66:978–984.
ScattoniML, CrawleyJ, RicceriL. 2009. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 33:508–515.
ScattoniML, GandhySU, RicceriL, CrawleyJN. 2008. Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism. PLoS One 3: e3067.
ScattoniML, RicceriL, CrawleyJN. 2011. Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters. Genes Brain Behav 10:44–56.
SchechterR, GretherJK. 2008. Continuing increases in autism reported to California's developmental services system: mercury in retrograde. Arch Gen Psychiatry 65:19–24.
SchneiderCW, ChenowethMB. 1970. Effects of hallucinogenic and other drugs on the nest-building behaviour of mice. Nature 225:1262–1263.
SchneiderT, PrzewlockiR. 2005. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30:80–89.
SchneiderT, TurczakJ, PrzewlockiR. 2006. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31:36–46.
SchumacherHJ, TerapaneJ, JordanRL, WilsonJG. 1972. The teratogenic activity of a thalidomide analogue, EM 12 in rabbits, rats, and monkeys. Teratology 5:233–240.
SchwarzE, GuestPC, RahmouneHet al. 2010. Sex-specific serum biomarker patterns in adults with Asperger's syndrome. Mol Psychiatry. Sep 28. [Epub ahead of print].
ShiL, FatemiSH, SidwellRW, PattersonPH. 2003. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23:297–302.
ShuW, ChoJY, JiangYet al. 2005. Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci USA 102:9643–9648.
ShultzSR, MacFabeDF, OssenkoppKPet al. 2008. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 54:901–911.
SiegelSJ, ConnollyP, LiangYet al. 2003. Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 28:675–682.
SigurdssonT, StarkKL, KarayiorgouM, GogosJA, GordonJA. 2010. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464:763–767.
SilvermanJL, ToluSS, BarkanCL, CrawleyJN. 2010. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35:976–989.
SilvermanJL, YangM, LordC, CrawleyJN. 2010. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 11:490–502.
SimpsonGV, KnightRT. 1993. Multiple brain systems generating the rat auditory evoked potential. I. Characterization of the auditory cortex response. Brain Res 602:240–250.
SingerHS, MorrisC, GauseCet al. 2009. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J Neuroimmunol 211:39–48.
SobinC, Kiley-BrabeckK, KarayiorgouM. 2005. Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry 10:553–562.
SohalVS, ZhangF, YizharO, DeisserothK. 2009. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459:698–702.
SokhadzeE, BaruthJ, TasmanAet al. 2009. Event-related potential study of novelty processing abnormalities in autism. Appl Psychophysiol Biofeedback 34:37–51.
SokhadzeEM, El-BazA, BaruthJ, MathaiG, SearsL, CasanovaMF. 2009. Effects of low frequency repetitive transcranial magnetic stimulation (rTMS) on gamma frequency oscillations and event-related potentials during processing of illusory figures in autism. J Autism Dev Disord 39:619–634.
StromlandK, NordinV, MillerM, AkerstromB, GillbergC. 1994. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36:351–356.
StrozikE, FestingMF. 1981. Whisker trimming in mice. Lab Anim 15:309–312.
SwerdlowNR, BraffDL, GeyerMA. 1999. Cross-species studies of sensorimotor gating of the startle reflex. Ann NY Acad Sci 877:202–216.
SzatmariP, PatersonAD, ZwaigenbaumLet al. 2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319–328.
TabuchiK, BlundellJ, EthertonMRet al. 2007. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318:71–76.
TakaraeY, MinshewNJ, LunaB, KriskyCM, SweeneyJA. 2004. Pursuit eye movement deficits in autism. Brain 127:2584–2594.
ThatcherRW, NorthDM, NeubranderJet al. 2009. Autism and EEG phase reset: deficient GABA mediated inhibition in thalamo-cortical circuits. Dev Neuropsychol 34:780–800.
ThomasA, BurantA, BuiNet al. 2009. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) 204:361–373.
ThompsonWW, PriceC, GoodsonBet al. 2007. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357:1281–1292.
TikhonravovD, NeuvonenT, PertovaaraAet al. 2008. Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats. Brain Res 1203:97–102.
TremolizzoL, DoueiriMS, DongEet al. 2005. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57:500–509.
UhlhaasPJ, SingerW. 2006. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 52:155–168.
UhlhaasPJ, SingerW. 2007. What do disturbances in neural synchrony tell us about autism?Biol Psychiatry 62:190–191.
UmbrichtD, KollerR, VollenweiderFX, SchmidL. 2002. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51:400–406.
UmbrichtD, VyssotkyD, LatanovAet al. 2004. Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans. Brain Res 1019:189–200.
UmbrichtD, VyssotkiD, LatanovA, NitschR, LippHP. 2005. Deviance-related electrophysiological activity in mice: is there mismatch negativity in mice?Clin Neurophysiol 116:353–363.
van HertenM, PasmanJ, van LeeuwenTHet al. 2008. Differences in AERP responses and atypical hemispheric specialization in 17-month-old children at risk of dyslexia. Brain Res 1201:100–105.
VaroqueauxF, AramuniG, RawsonRLet al. 2006. Neuroligins determine synapse maturation and function. Neuron 51:741–754.
Vianney-RodriguesP, IancuOD, WelshJP. 2011. Gamma oscillations in the auditory cortex of awake rats. Eur J Neurosci 33:119–129.
VidingE, BlakemoreSJ. 2007. Endophenotype approach to developmental psychopathology: implications for autism research. Behav Genet 37:51–60.
WallaceS, SebastianC, PellicanoE, ParrJ, BaileyA. 2010. Face processing abilities in relatives of individuals with ASD. Autism Res 3:345–349.
WangK, ZhangH, MaDet al. 2009. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459:528–533.
WangX. 2004. The unexpected consequences of a noisy environment. Trends Neurosci 27:364–366.
WangY, GreenwoodJS, CalcagnottoMEet al. 2007. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol 61:139–152.
WassinkTH, HazlettHC, EppingEAet al. 2007. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 64:709–717.
WeissLA, ArkingDE, DalyMJ, ChakravartiA. 2009. A genome-wide linkage and association scan reveals novel loci for autism. Nature 461:802–808.
WelshJP, AhnES, PlacantonakisDG. 2005. Is autism due to brain desynchronization?Int J Dev Neurosci 23:253–263.
WelshJP, RodriguesPV, EdgarJC, RobertsTPL. 2010. Gamma band oscillopathy: an electrical signature of language impairment in ASD that impairs active listening. Intl Meeting for Autism Res (IMFAR), International Society for Autism Research 109. [Accessed 25 Apr 2011.] Available at:
WhiteNR, PrasadM, BarfieldRJ, NybyJG. 1998. 40- and 70-kHz vocalizations of mice (Mus musculus) during copulation. Physiol Behav 63:467–473.
WhiteSA, FisherSE, GeschwindDH, ScharffC, HolyTE. 2006. Singing mice, songbirds, and more: models for FOXP2 function and dysfunction in human speech and language. J Neurosci 26:10376–10379.
WilkersonDS, VolpeAG, DeanRS, TitusJB. 2002. Perinatal complications as predictors of infantile autism. Int J Neurosci 112:1085–1098.
WilliamsK, WheelerDM, SiloveN, HazellP. 2010. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev:CD004677.
WilliamsKW, WrayJJ, WheelerDM. 2005. Intravenous secretin for autism spectrum disorder. Cochrane Database Syst Rev: CD003495.
WilliamsLM, WhitfordTJ, NagyMet al. 2009. Emotion-elicited gamma synchrony in patients with first-episode schizophrenia: a neural correlate of social cognition outcomes. J Psychiatry Neurosci 34:303–313.
WilsonTW, RojasDC, ReiteML, TealePD, RogersSJ. 2007. Children and adolescents with autism exhibit reduced MEG steady-state gamma responses. Biol Psychiatry 62:192–197.
WinslowJT. 2003. Mouse social recognition and preference. Curr Protoc Neurosci Ch. 8: Unit 8.16.
WinterC, ReutimanTJ, FolsomTDet al. 2008. Dopamine and serotonin levels following prenatal viral infection in mouse–implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18:712–716.
WittRM, GalliganMM, DespinoyJR, SegalR. 2009. Olfactory behavioral testing in the adult mouse. J Vis Exp 23:949.
WitterFR, ZimmermanAW, ReichmannJP, ConnorsSL. 2009. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol 201:553–559.
YamadaK. 2010. Strain differences of selective attention in mice: effect of Kamin blocking on classical fear conditioning. Behav Brain Res 213:126–129.
YamawakiN, StanfordIM, HallSD, WoodhallGL. 2008. Pharmacologically induced and stimulus evoked rhythmic neuronal oscillatory activity in the primary motor cortex in vitro. Neuroscience 151:386–395.
YanQJ, RammalM, TranfagliaM, BauchwitzRP. 2005. Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49:1053–1066.
YangM, PerryK, WeberMD, KatzAM, CrawleyJN. 2011. Social peers rescue autism-relevant sociability deficits in adolescent mice. Autism Res 4:17–27.
YoungDM, SchenkAK, YangSB, JanYN, JanLY. 2010. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Proc Natl Acad Sci USA 107:11074–11079.
ZengLH, XuL, GutmannDH, WongM. 2008. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444–453.
ZerrateMC, PletnikovM, ConnorsSLet al. 2007. Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther 322:16–22.
ZhangC, MilunskyJM, NewtonSet al. 2009. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci 29:10843–10854.
ZhangL, HeJ, JugloffDG, EubanksJH. 2008. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18:294–309.
ZhouJ, BlundellJ, OgawaSet al. 2009. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 29:1773–1783.
ZimmermanAW. 2005. The immune system. In The Neurobiology of Autism. BaumanML, KemperTL, eds. Baltimore, MD: Johns Hopkins University Press, pp. 371–386.